Skip to main content
. Author manuscript; available in PMC: 2022 Aug 21.
Published in final edited form as: Eur J Pharm Sci. 2020 Jun 18;152:105432. doi: 10.1016/j.ejps.2020.105432

Figure 6.

Figure 6.

Pharmacokinetic profiles and calculated parameters of nanosuspension (NS2-G), suspension (SUSP) and solution (SOL) in (a) plasma, (b) brain, (c) liver and (d) kidney after intraperitoneal administration in mice (n = 3 per time point) at dose of 10 mg/kg. Cmax – maximum concentration; tmax – time of maximum concentration; AUC0–36 – area under the concentration versus time curve from zero to last measurable time point; t1/2 - terminal elimination half-life.